You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PD-1 antibody

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Parkinson Disease Trial in China (Pramipexole SR, Pramipexole IR)

Completed
Has Results
  • Parkinson Disease
  • Pramipexole SR
  • Pramipexole IR
  • Beijing, China
  • +11 more
Feb 8, 2021

Type 1 Diabetes Trial in Rochester (procedure, other, dietary supplement)

Not yet recruiting
  • Type 1 Diabetes
  • Muscle Biopsy
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Aug 2, 2023

Arrhythmias, Cardiac, Venous Puncture, Implantable Defibrillator User Trial in Ferrara (Ultrasound Guided Axillary Venous

Recruiting
  • Arrhythmias, Cardiac
  • +5 more
  • Ultrasound Guided Axillary Venous Access
  • Fluoroscopy-Guided Axillary Venous Access
  • Ferrara, Italy
    Azienda Ospedaliero-Universitaria di Ferrara
Nov 25, 2022

Breast Cancer Trial in United States (ARV-471, Ribociclib)

Not yet recruiting
  • Breast Cancer
  • Shiloh, Illinois
  • +8 more
Feb 1, 2023

Prostate Cancer Metastatic Trial in United States (FOR46)

Active, not recruiting
  • Prostate Cancer Metastatic
  • Los Angeles, California
  • +4 more
May 9, 2022

Clear Cell Renal Cell Carcinoma Trial in Worldwide (Belzutifan, Pembrolizumab, Placebo)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Duarte, California
  • +250 more
Jan 27, 2023

Atopic Dermatitis (AD) Trial (0.3% OPA-15406 Ointment, 1% OPA-15406 Ointment, 0% OPA-15406 vehicle)

Not yet recruiting
  • Atopic Dermatitis (AD)
  • 0.3% OPA-15406 Ointment
  • +2 more
  • (no location specified)
Jan 28, 2023

Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the National Cancer Institute (NCI) (Venetoclax, Ibrutinib, Prednisone)

Recruiting
  • Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 20, 2022

Renal Cancer Trial in New York (124IcG250)

Active, not recruiting
  • Renal Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 4, 2022

COVID-19 Trial in Nanjing (recombinant Ad5 vectored COVID-19 vaccine, RBD-based protein subunit vaccine (ZF2001) against

Completed
  • COVID-19
  • recombinant Ad5 vectored COVID-19 vaccine
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Diseases Control and Prevention
Mar 28, 2022

Gut Flora in Parkinson's Disease: a Pilot Study

Recruiting
  • Parkinson Disease
    • Aberdeen, Aberdeen City, United Kingdom
      Human Nutrition Unit, Rowett Institute, University of Aberdeen
    Mar 15, 2023

    Hepatitis A, Human Immunodeficiency Virus, Vaccine Response Impaired Trial in Taipei (Vaqta Injectable Product)

    Recruiting
    • Hepatitis A
    • +2 more
    • Vaqta Injectable Product
    • Taipei, Taiwan
      National Taiwan University Hospital
    Mar 14, 2021

    Polycystic Liver Disease Trial in Rochester, Dallas (CAM2029, Placebo)

    Recruiting
    • Polycystic Liver Disease
    • Rochester, Minnesota
    • +6 more
    Jan 18, 2023

    Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))

    Suspended
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Stanford, California
      Stanford Cancer Institute Palo Alto
    Sep 21, 2022

    Respiratory Syncytial Virus Trial in Worldwide (mRNA-1345, Placebo)

    Recruiting
    • Respiratory Syncytial Virus
    • mRNA-1345
    • Placebo
    • Birmingham, Alabama
    • +61 more
    Nov 19, 2023

    HER2-positive Breast Cancer Trial in Chengdu (Recombinant anti-HER2 humanized mAb conjugate for injection.R&D code: B003.)

    Active, not recruiting
    • HER2-positive Breast Cancer
    • Recombinant anti-HER2 humanized monoclonal antibody conjugate for injection.R&D code: B003.
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Jan 30, 2023

    Melanoma (Excluding Uveal Melanoma), Cervical Carcinoma, Pancreatic Carcinoma Trial in United States (XmAb®23104, Yervoy®

    Recruiting
    • Melanoma (Excluding Uveal Melanoma)
    • +15 more
    • XmAb®23104
    • Yervoy® (ipilimumab)
    • San Diego, California
    • +15 more
    Sep 20, 2021

    Metastatic Colorectal Cancer Trial in China (Anlotinib HCl capsule, Bevacizumab, Oxaliplatin)

    Recruiting
    • Metastatic Colorectal Cancer
    • Anlotinib hydrochloride capsule
    • +3 more
    • Fuzhou, Anhui, China
    • +4 more
    Aug 17, 2021

    Older Adults Institutionalized in Residential Homes Trial in Cáceres (Technological devices intervention (use of tablet and big

    Recruiting
    • Older Adults Institutionalized in Residential Homes
    • Technological devices intervention (use of tablet and big screen with games oriented to training physical and cognitive function)
    • Cáceres, Extremadura, Spain
      University of Extremadura
    May 26, 2023

    Post COVID-19 Condition (PCC) Trial in E. Amherst, Milan (RDX-19)

    Recruiting
    • Post COVID-19 Condition (PCC)
    • RDX-19
    • E. Amherst, New York
    • +1 more
    Oct 30, 2023

    HER2 Positive Metastatic Breast Cancer Trial in Worldwide (ARX788)

    Active, not recruiting
    • HER2 Positive Metastatic Breast Cancer
    • Glendale, California
    • +52 more
    Oct 25, 2022

    Anemia and Growth Assessment in Acute Gastroenteritis

    Not yet recruiting
    • Acute Gastroenteritis
      • (no location specified)
      Sep 14, 2023

      Immune Checkpoint Inhibitor in NSCLC Patients

      Not yet recruiting
      • Adverse Reactions
      • +3 more
      • renin-angiotensin system inhibitors or angiotensin-receptor-neprilysin inhibitor
      • (no location specified)
      Jul 15, 2020

      Pulmonary Hypertension Trial in Gothenburg, Örebro (PDNO, Sodium chloride ())

      Recruiting
      • Pulmonary Hypertension
      • PDNO
      • Sodium chloride (placebo)
      • Gothenburg, Sweden
      • +1 more
      Jan 17, 2023

      Advanced Solid Tumor Trial in Canton, Austin, San Antonio (Tipifarnib)

      Recruiting
      • Advanced Solid Tumor
      • Canton, Ohio
      • +2 more
      Aug 19, 2022